Grupo de Neurobioloxia Molecular e Celular da Enfermidade de Parkinson
Parkinson neurobiol
Complexo Hospitalario Universitario de Vigo
Vigo, EspañaPublicacións en colaboración con investigadores/as de Complexo Hospitalario Universitario de Vigo (6)
2023
-
AT1 receptor autoantibodies mediate effects of metabolic syndrome on dopaminergic vulnerability
Brain, Behavior, and Immunity, Vol. 108, pp. 255-268
2022
-
Angiotensin type-1 receptor and ACE2 autoantibodies in Parkinson´s disease
npj Parkinson's Disease, Vol. 8, Núm. 1
-
Beta-Blocker Exposure and Survival in Patients With Transthyretin Amyloid Cardiomyopathy
Mayo Clinic Proceedings, Vol. 97, Núm. 2, pp. 261-273
-
Cardiac amyloidosis: Description of a series of 143 cases
Medicina Clinica, Vol. 159, Núm. 5, pp. 207-213
-
Syncope in patients with transthyretin amyloid cardiomyopathy: clinical features and outcomes
Postgraduate Medicine, Vol. 134, Núm. 4, pp. 420-428
2020
-
Interaction between brain angiotensin and dopaminergic systems and Parkinson’s disease
Genetics, Neurology, Behavior, and Diet in Parkinson’s Disease: The Neuroscience of Parkinson’s Disease, Volume 2 (Elsevier), pp. 463-477